期刊文献+

乳鼠心肌细胞分离表达CD80/CD86减弱CTL杀伤

CD80,BUT NOT CD86 EXPRESSION ON CULTURED NEONATAL MICE CARDIOMYOCYTES ATTENUATE THE CTL-MEDIATE LYSIS
下载PDF
导出
摘要 [目的]研究乳鼠心肌细胞CD80/CD86的表达模式并分析该表达模式对同种异体淋巴细胞的功能影响。[方法]取BALB/c(H-2d)和C57BL/6(H-2b)乳鼠心脏,分离培养心肌细胞,用RT-PCR及免疫荧光测CD80/CD86表达。将培养10d乳鼠心肌细胞与预活化CTL共培养4h,同时另设CD80或CTLA-4封闭组,计算CTL杀伤率。[结果]培养的乳鼠心肌细胞表达CD80,不表达CD86。单独表达CD80心肌细胞通过CD80与CTLA-4结合减弱CTL杀伤。[结论]培养的乳鼠心肌细胞单独表达CD80共刺激分子能有效抑制CTL杀伤。 [ Objective] To investigate the expression pattern of CD80/CD86 on neonatal mice cardiomyocytes and how the cells work when they meet aUogenic lymphocytes. [Methods] Cardiomyocytes were isolated from neonatal BALB/c or C57 mice and cultured for 10 days, then stained with CD80/CD86 antibodies and analyzed by immunofluorescence. CD80/CD86 mRNA were also analyzed by RT-PCR. Effector CTLs were C57 splenocytes which were incubated with stimulator cells (BALB/ c splenocytes) for 2 weeks to yield matured CTL. Target cells were cultured BALB/c cardiomyocytes. [ Results] CD80, but not CD86 expressed on cardiomyocytes after 10 days culture and the cells attenuated the CTL-mediate lysis through the combi- nation of CD80 and CTLA-4. [Conclusions] The neonatal mice cardiomyocytes expressing CD80 costimulator exclusively can inhibit the killing of CTL effectively.
出处 《现代预防医学》 CAS 北大核心 2007年第3期421-423,共3页 Modern Preventive Medicine
基金 国家自然科学基金项目(30371355)
关键词 心肌细胞 共刺激分子 细胞毒性淋巴细胞 Cardiomyocyte Costimulator CTL
  • 相关文献

参考文献1

二级参考文献10

  • 1Landmesser U,Engberding N,Bahlmann FH.Statin-induced improvement of endothelial progenitor cell mobilization,myocardial neovascularization,left ventricular function,and survival after experimental myocardial infarction requires endothelial nitric oxide synthase[].Circulation.2004
  • 2von Haehling S,Okonko DO,Anker SD.Statins:a treatment option for chronic heart failure?[].Heart Fail Monitor.2004
  • 3Landmesser U,Bahlmann F,Mueller M,et al.Simvastatin versus ezetimibe:pleiotropic and lipid-lowering effects on endothelial function in humans[].Circulation.2005
  • 4Cannon CP,Braunwald E,McCabe CH,et al.Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[].The New England Journal of Medicine.2004
  • 5Banach M,Okonski P.Role of statins in the treatment of heart diseases.Heart failure[].Guide Gps.2005
  • 6Packard C.Improving outcomes through statin therapy-a review of ongoing trials[].European Heart Journal.2004
  • 7Banach M,,Okonski P.AMS congress report.Heart Failure and Europace 2005[].Arch Med Sci.2005
  • 8Banach M.Role of statins in treatment of cardiovascular diseases in elderly patients[].Pol Geriatr.2005
  • 9Kjekshus J.Debate:statins should be used in patients with heart failure[].Curt Control Trials Cardiovasc Med.2001
  • 10von Haehling S,Anker SD.Statins for heart failure:at the crossroads between cholesterol reduction and pleiotropism?[].Heart.2005

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部